[Somatostatin receptor PET/CT (SSTR-PET/CT)].
作者： C. Boy , T. Poeppel , J. Kotzerke , B. J. Krause , H. Amthauer
关键词:
摘要: The present guideline is focused on quality assurance of somatostatin receptor PET/CT (SSTR-PET/CT) in oncology patients. document has been developed by a multidisciplinary board specialists providing consensus definitions, prerequisites, methodology, operating procedures, assessment, and standardized reporting. In particular, imaging procedures for the two most commonly used radioligands human SSTR, i. e. 68Ga-DOTATOC 68Ga-DOTATATE are presented. Overall, SSTR-PET/CT requires close interdisciplinary communication cooperation referring executing medical disciplines, taking into account existing guidelines recommendations European German societies, including Association Nuclear Medicine (EANM), Society Endocrinology (DGE), (DGN) Radiology (DRG).
thieme-connect.de
ru.nl参考文章(40)
B.-J. Krause, T. Beyer, A. Bockisch, D. Delbeke, J. Kotzerke, V. Minkov, M. Reiser, N. Willich, FDG-PET/CT in der Onkologie Nuklearmedizin-nuclear Medicine. ,vol. 46, pp. 291- 301 ,(2007) , 10.3413/NUKMED-282
Jean Reubi, Beatrice Waser, Jean-Claude Schaer, Jean A. Laissue, Somatostatin receptor sst1–sst5 expression in normal and neoplastic human tissues using receptor autoradiography with subtype-selective ligands European Journal of Nuclear Medicine and Molecular Imaging. ,vol. 28, pp. 836- 846 ,(2001) , 10.1007/S002590100598
G. Pöpperl, H. Amthauer, J. Nagarajah, F. Rösch, K. Scheidhauer, J. Kotzerke, R. P. Baum, D. Schmidt, B. J. Krause, D. Führer, C. Boy, S. Ezziddin, H. Lahner, I. Buchmann, M. A. Walter, A. Bockisch, D. Hörsch, T. D. Poeppel, Peptide receptor radionuclide therapy for patients with somatostatin receptor expressing tumours Nuklearmedizin. ,vol. 54, pp. 1- 11 ,(2015)
K. Zöphel, R. Freudenberg, L. Oehme, M. Andreeff, G. Wunderlich, G. Eisenhofer, J. Kotzerke, H. Hartmann, Radiation exposure of patients during 68Ga-DOTATOC PET/CT examinations Nuklearmedizin-nuclear Medicine. ,vol. 48, pp. 201- 207 ,(2009) , 10.3413/NUKMED-0214
Serkan Kuyumcu, Zeynep Gözde Özkan, Yasemin Sanli, Ebru Yilmaz, Ayse Mudun, Isik Adalet, Seher Unal, Physiological and tumoral uptake of (68)Ga-DOTATATE: standardized uptake values and challenges in interpretation. Annals of Nuclear Medicine. ,vol. 27, pp. 538- 545 ,(2013) , 10.1007/S12149-013-0718-4
Christian Boy, Till A. Heusner, Thorsten D. Poeppel, Anja Redmann-Bischofs, Nicole Unger, Walter Jentzen, Wolfgang Brandau, Klaus Mann, Gerald Antoch, Andreas Bockisch, Stephan Petersenn, 68Ga-DOTATOC PET/CT and somatostatin receptor (sst1-sst5) expression in normal human tissue: correlation of sst2 mRNA and SUVmax European Journal of Nuclear Medicine and Molecular Imaging. ,vol. 38, pp. 1224- 1236 ,(2011) , 10.1007/S00259-011-1760-X
Giorgio Treglia, Paola Castaldi, Guido Rindi, Alessandro Giordano, Vittoria Rufini, Diagnostic performance of Gallium-68 somatostatin receptor PET and PET/CT in patients with thoracic and gastroenteropancreatic neuroendocrine tumours: a meta-analysis. Endocrine. ,vol. 42, pp. 80- 87 ,(2012) , 10.1007/S12020-012-9631-1
Camilla Bardram Johnbeck, Ulrich Knigge, Andreas Kjær, PET tracers for somatostatin receptor imaging of neuroendocrine tumors: current status and review of the literature. Future Oncology. ,vol. 10, pp. 2259- 2277 ,(2014) , 10.2217/FON.14.139
M. Gabriel, C. Decristoforo, D. Kendler, G. Dobrozemsky, D. Heute, C. Uprimny, P. Kovacs, E. Von Guggenberg, R. Bale, I. J. Virgolini, 68Ga-DOTA-Tyr3-Octreotide PET in Neuroendocrine Tumors: Comparison with Somatostatin Receptor Scintigraphy and CT The Journal of Nuclear Medicine. ,vol. 48, pp. 508- 518 ,(2007) , 10.2967/JNUMED.106.035667
Irina Velikyan, Anders Sundin, Barbro Eriksson, Hans Lundqvist, Jens Sörensen, Mats Bergström, Bengt Långström, In vivo binding of [68Ga]-DOTATOC to somatostatin receptors in neuroendocrine tumours — impact of peptide mass Nuclear Medicine and Biology. ,vol. 37, pp. 265- 275 ,(2010) , 10.1016/J.NUCMEDBIO.2009.11.008